News

Oracle's Options Market Activity Evidences Strong Investor Interest

Oracle's Options Market Activity Evidences Strong Investor Interest

Strong Investor Sentiment Reflected in Oracle's Options Market

There's been a notable surge of interest in Oracle (NYSE: ORCL) lately, particularly in the options market. A thorough analysis of the options trades related to this tech giant reveals a clear sign of bullish activity, suggesting that investors are increasingly confident about Oracle's future.

A review of recent options transactions has shown an impressive 39 unusual trades for Oracle. Among these trades, 53% of the participants displayed a bullish sentiment, while 35% took a bearish stance. This divergence in opinions sheds light on the differing perspectives investors have regarding the stock's upcoming movements.

Investment Sentiments and Trade Details

Out of the trades we analyzed, just 4 were puts, totaling a value of $139,890. In comparison, a far larger number of 35 trades were calls, which amounted to around $3,947,276. This significant difference signals a clear preference for upward movement in Oracle's stock among traders in the near term.

Anticipated Price Movements

By examining the trading volumes and open interest, it's evident that Oracle's major market players are eyeing a price range between $130 and $230. This specific price band reflects what traders expect for Oracle's stock over the next few months, offering insights into overall market expectations.

Examining Volume and Open Interest for Better Strategies

Understanding metrics like volume and open interest is essential for anyone involved in the options market. These figures reveal liquidity and how engaged investors are with Oracle's options, especially at different strike prices. The data below illustrates trends in volume and open interest related to several of Oracle's key trades, focusing on strike prices between $130 and $230 over the last month.

Recent Activity in Oracle's Options Market

A closer look at options trading for Oracle points to a very active market. Here’s an overview of some noteworthy options activity:

The options trades for Oracle have included a variety of contract types, mainly leaning toward calls. Here’s detailed information about several recent trades that reflect strong market interest:

  • Symbol: ORCL | Type: CALL | Trade Type: Trade | Sentiment: Bullish | Expiration Date: 12/20/24 | Trade Value: $1.7M | Strike Price: $185.00 | Open Interest: 665
  • Symbol: ORCL | Type: CALL | Trade Type: Sweep | Sentiment: Neutral | Expiration Date: 11/15/24 | Trade Value: $264.7K | Strike Price: $175.00 | Open Interest: 1.3K
  • Symbol: ORCL | Type: CALL | Trade Type: Sweep | Sentiment: Bullish | Expiration Date: 09/27/24 | Trade Value: $178.0K | Strike Price: $165.00 | Open Interest: 1.5K
  • Symbol: ORCL | Type: CALL | Trade Type: Trade | Sentiment: Bearish | Expiration Date: 11/15/24 | Trade Value: $177.5K | Strike Price: $180.00 | Open Interest: 710
  • Symbol: ORCL | Type: CALL | Trade Type: Trade | Sentiment: Bullish | Expiration Date: 09/27/24 | Trade Value: $123.0K | Strike Price: $165.00 | Open Interest: 1.5K

Overview of Oracle Corporation

Since its founding in 1977, Oracle has played a pivotal role in database technologies and enterprise resource planning (ERP) solutions. The company was a pioneer in introducing the first commercial SQL-based relational database management system, greatly influencing data management practices. With a client base of 430,000 across 175 countries, Oracle has developed a strong reputation, bolstered by a workforce of 136,000 employees.

Reviewing the activity in Oracle's options provides critical insights into investor behavior and expectations regarding the company's future performance.

Current Status of Oracle's Stock

  • Oracle’s recent trading volume stands at 8,897,618, marking a 4.89% increase, with the stock trading at approximately $169.96.
  • The current RSI indicators suggest the stock may be entering overbought territory.
  • Investors are waiting for the next earnings report, expected in about 84 days.

Engaging in options trading can be both challenging and rewarding. Savvy traders work to mitigate risks by continuously honing their knowledge, refining strategies, and closely observing market changes. To stay on top of Oracle's options activities and forecasts, consider setting up real-time alerts.

Frequently Asked Questions

What services does Oracle provide?

Oracle offers top-tier database technology and enterprise resource planning software to businesses worldwide.

What’s attracting investors to Oracle’s options?

Investors are keenly interested in Oracle's options due to signs of substantial bullish trends and the potential for favorable stock price movements.

What is the current trading price of Oracle's stock?

Currently, Oracle’s stock is trading at around $169.96, showing an uptick recently.

How can I keep up with Oracle's market developments?

Investors can receive timely market updates and alerts about Oracle's options trading through different financial news platforms.

What should newcomers to trading keep in mind about options trading?

New traders need to focus on learning about risks, effective strategies, and the key metrics that influence options trading.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

CeraVe Marks 20 Years of Groundbreaking Skincare Innovations

Updated Category News Views 259

CeraVe's Celebrated Journey in Skincare CeraVe is making waves as it marks an impressive milestone: 20 years of dedicated skincare science. Launching with the mission to nurture and restore skin health, the brand has garnered an extensive following of both customers and dermatology professionals worldwide. By focusing on skin barrier health and utilizing innovative...

Continue Reading
Exploring Novartis' Latest Innovations in Hematology and Oncology

Updated Category News Views 320

Novartis Pioneers Innovations in Hematology and Oncology Basel – Novartis has been making headlines with groundbreaking data presented at major medical meetings, including the esteemed American Society of Hematology (ASH) Annual Meeting and the San Antonio Breast Cancer Symposium (SABCS). This year, Novartis is showcasing over 70 abstracts with significant findings that...

Continue Reading
Sustainable Green Team Reveals Patents for Eco-Innovation

Updated Category News Views 189

Innovative Patents by Sustainable Green Team Sustainable Green Team, Ltd. (OTC: SGTM) is making significant strides in environmental responsibility by filing an impressive portfolio of 20 U.S. provisional patent applications. This initiative marks the unveiling of the SGTM 20-Patent Fortress™, consolidating the company's dedication to revolutionizing waste management...

Continue Reading
SSL's C2PA Game Changer: Authenticity or Just Hype?

Updated Category News Views 172

SSL just dropped a bombshell on the digital content authenticity scene. On February 18, 2026, they announced themselves as the first publicly trusted certificate authority to roll out production-ready C2PA-conformant certificates. But what’s behind all this noise? Desks are buzzing about whether this marks a real breakthrough against deepfakes and misinformation or if...

Continue Reading
MiMedia's Innovations at Mobile World Congress Excite Investors

Updated Category News Views 95

MiMedia Partners with Orbic at Mobile World Congress MiMedia Holdings Ltd. is excited to announce its collaboration with Orbic, a prominent US OEM, to develop and market the new line of rugged devices under the Caterpillar brand. This partnership was highlighted during the recently attended Mobile World Congress conference, where innovative trends within the tech industry...

Continue Reading